https://www.selleckchem.com/pr....oducts/BafilomycinA1
CT02439320 ); SPARTAN ( NCT02605174 ). SAMURAI ( NCT02439320 ); SPARTAN ( NCT02605174 ). Most patients with acute pancreatitis (AP) experience mild, self-limiting disease with little or no need for hospital care. However, 20-25% of patients develop a more severe and potentially life-threatening condition with progressive systemic inflammatory response syndrome (SIRS) and multiorgan failure, resulting in high morbidity and mortality rates. Predicting disease severity at an early stage is important, as immediate supportive care has
Like
Comment
Share
